175 related articles for article (PubMed ID: 25492424)
1. Recent successes in the identification, development, and qualification of translational biomarkers: the next generation of kidney injury biomarkers.
Ennulat D; Adler S
Toxicol Pathol; 2015 Jan; 43(1):62-9. PubMed ID: 25492424
[TBL] [Abstract][Full Text] [Related]
2. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
Amacher DE
Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies.
Vlasakova K; Erdos Z; Troth SP; McNulty K; Chapeau-Campredon V; Mokrzycki N; Muniappa N; Gu YZ; Holder D; Bailey WJ; Sistare FD; Glaab WE
Toxicol Sci; 2014 Mar; 138(1):3-20. PubMed ID: 24361871
[TBL] [Abstract][Full Text] [Related]
4. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.
Harpur E; Ennulat D; Hoffman D; Betton G; Gautier JC; Riefke B; Bounous D; Schuster K; Beushausen S; Guffroy M; Shaw M; Lock E; Pettit S;
Toxicol Sci; 2011 Aug; 122(2):235-52. PubMed ID: 21593213
[TBL] [Abstract][Full Text] [Related]
5. Qualified kidney biomarkers and their potential significance in drug safety evaluation and prediction.
Xie HG; Wang SK; Cao CC; Harpur E
Pharmacol Ther; 2013 Jan; 137(1):100-7. PubMed ID: 23017937
[TBL] [Abstract][Full Text] [Related]
6. Assessment of biomarkers of drug-induced kidney injury in cynomolgus monkeys treated with a triple reuptake inhibitor.
Guha M; Heier A; Price S; Bielenstein M; Caccese RG; Heathcote DI; Simpson TR; Stong DB; Bodes E
Toxicol Sci; 2011 Apr; 120(2):269-83. PubMed ID: 21258088
[TBL] [Abstract][Full Text] [Related]
7. Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes.
Brott DA; Furlong ST; Adler SH; Hainer JW; Arani RB; Pinches M; Rossing P; Chaturvedi N;
Drug Des Devel Ther; 2015; 9():3191-8. PubMed ID: 26124642
[TBL] [Abstract][Full Text] [Related]
8. Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury.
Wadey RM; Pinches MG; Jones HB; Riccardi D; Price SA
Toxicol Pathol; 2014; 42(3):591-602. PubMed ID: 23823703
[TBL] [Abstract][Full Text] [Related]
9. Brief Overview: Assessment of Compound-induced Acute Kidney Injury Using Animal Models, Biomarkers, and In Vitro Platforms.
McDuffie JE
Toxicol Pathol; 2018 Dec; 46(8):978-990. PubMed ID: 30392454
[TBL] [Abstract][Full Text] [Related]
10. Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers.
Keirstead ND; Wagoner MP; Bentley P; Blais M; Brown C; Cheatham L; Ciaccio P; Dragan Y; Ferguson D; Fikes J; Galvin M; Gupta A; Hale M; Johnson N; Luo W; McGrath F; Pietras M; Price S; Sathe AG; Sasaki JC; Snow D; Walsky RL; Kern G
Toxicol Sci; 2014 Feb; 137(2):278-91. PubMed ID: 24189134
[TBL] [Abstract][Full Text] [Related]
11. Preclinical perspective of urinary biomarkers for the detection of nephrotoxicity: what we know and what we need to know.
Fuchs TC; Hewitt P
Biomark Med; 2011 Dec; 5(6):763-79. PubMed ID: 22103611
[TBL] [Abstract][Full Text] [Related]
12. Validation of putative genomic biomarkers of nephrotoxicity in rats.
Wang EJ; Snyder RD; Fielden MR; Smith RJ; Gu YZ
Toxicology; 2008 Apr; 246(2-3):91-100. PubMed ID: 18289764
[TBL] [Abstract][Full Text] [Related]
13. Assessment standards: comparing histopathology, digital image analysis, and stereology for early detection of experimental cisplatin-induced kidney injury in rats.
Shea K; Stewart S; Rouse R
Toxicol Pathol; 2014 Aug; 42(6):1004-15. PubMed ID: 24201815
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of drug-induced acute kidney injury: a regulatory perspective.
Blank M; Thompson A; Hausner E; Rouse R
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):929-936. PubMed ID: 30099912
[TBL] [Abstract][Full Text] [Related]
15. Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media.
Rouse RL; Stewart SR; Thompson KL; Zhang J
Toxicol Pathol; 2013; 41(4):662-80. PubMed ID: 23085980
[TBL] [Abstract][Full Text] [Related]
16. Comparison between male and female Sprague-Dawley rats in the response of urinary biomarkers to injury induced by gentamicin.
Gautier JC; Gury T; Guffroy M; Masson R; Khan-Malek R; Hoffman D; Pettit S; Harpur E
Toxicol Pathol; 2014 Oct; 42(7):1105-16. PubMed ID: 24717899
[TBL] [Abstract][Full Text] [Related]
17. Impact of biomarker development on drug safety assessment.
Marrer E; Dieterle F
Toxicol Appl Pharmacol; 2010 Mar; 243(2):167-79. PubMed ID: 20036272
[TBL] [Abstract][Full Text] [Related]
18. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies.
Benjamin A; Gallacher DJ; Greiter-Wilke A; Guillon JM; Kasai C; Ledieu D; Levesque P; Prelle K; Ratcliffe S; Sannajust F; Valentin JP
J Pharmacol Toxicol Methods; 2015; 75():101-10. PubMed ID: 25637943
[TBL] [Abstract][Full Text] [Related]
19. Safety biomarkers in preclinical development: translational potential.
Sasseville VG; Mansfield KG; Brees DJ
Vet Pathol; 2014 Jan; 51(1):281-91. PubMed ID: 24091814
[TBL] [Abstract][Full Text] [Related]
20. The current status of biomarkers for predicting toxicity.
Campion S; Aubrecht J; Boekelheide K; Brewster DW; Vaidya VS; Anderson L; Burt D; Dere E; Hwang K; Pacheco S; Saikumar J; Schomaker S; Sigman M; Goodsaid F
Expert Opin Drug Metab Toxicol; 2013 Nov; 9(11):1391-408. PubMed ID: 23961847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
